C12N 9/485
Exopeptidases
Official title: {Exopeptidases (3.4.11-3.4.19)}
C12N9/485 (Exopeptidases) appears on 205 US grants and 509 published applications in this corpus.
Search patents in C12N- Granted patents
- 205
- Published applications
- 509
- Assignees
- 311
- Inventors
- 1,140
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 0 | 3 |
| 2012 | 1 | 1 |
| 2013 | 0 | 12 |
| 2014 | 5 | 13 |
| 2015 | 8 | 21 |
| 2016 | 7 | 22 |
| 2017 | 15 | 16 |
| 2018 | 10 | 16 |
| 2019 | 12 | 24 |
| 2020 | 14 | 34 |
| 2021 | 14 | 35 |
| 2022 | 22 | 59 |
| 2023 | 19 | 86 |
| 2024 | 25 | 83 |
| 2025 | 27 | 42 |
| 2026 | 22 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Digital microbiology15 Sep 2026US 12,735,735 B2Bio-Rad Europe GmbH
- Immobilized proteases for activation of the zymogen form of transglutaminase25 Aug 2026US 12,716,059 B2Curie Co. Inc.
- Non-human animals comprising a humanized ACE2 locus11 Aug 2026US 12,702,122 B2Regeneron Pharmaceuticals, Inc.
- Soluble ACE2 protein, fusion proteins thereof with an FC domain, and methods of treatment of an ACE2-related disease21 Jul 2026US 12,686,860 B2Huahui Health Ltd.
- ACE2 muteins and methods of using the same7 Jul 2026US 12,674,153 B2Emmune, Inc.
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Prophylactic/therapeutic agent for pregnancy-induced hypertension8 Oct 2026US 2026/0308559 A1Medical Corporation Saneikai
- Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides1 Oct 2026US 2026/0297153 A1
- Archaeal peptide recombinase – a novel peptide ligating enzyme17 Sep 2026US 2026/0275319 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Method for treating covid-19 infection in a human subject10 Sep 2026US 2026/0263510 A1Imam Abdulrahman Bin Faisal University
Most cited
By later US patents
- Molecules and methods for iterative polypeptide analysis and processing57US 9,435,810 B2Washington University · 2016
- Methods of generating desired amino-terminal residues in proteins51US 5,093,242 AMassachusetts Institute of Technology · 1992
- Induced activation in dendritic cell40US 7,404,950 B2Baylor College of Medicine · 2008
- Induced activation in dendritic cells35US 8,999,949 B2Baylor College of Medicine · 2015
- PSMA binding ligand-linker conjugates and methods for using34US 9,951,324 B2Purdue Research Foundation · 2018